Millions of people will continue to be diagnosed with cancer every year for the foreseeable
future. These patients all need access to optimum health care. Population-based cancer …

Reliable epidemiological information on chronic myeloproliferative disorders (CMPDs),
notably Philadelphia (Ph)/BCR-ABL-positive chronic myeloid leukaemia (CML), is rare …

EUROCARE-4 analysed about three million adult cancer cases from 82 cancer registries in
23 European countries, diagnosed in 1995–1999 and followed to December 2003. For each …

Objective To examine changes in temporal trends in breast cancer mortality in women living
in 30 European countries. Design Retrospective trend analysis. Data source WHO mortality …

Background EUROCARE is the largest population-based cooperative study on survival of
patients with cancer. The EUROCARE project aims to regularly monitor, analyse, and …

Colorectal cancer (CRC) is the second most common cause of death due to cancer causing
death in Europe, accounting for more than 200,000 deaths per year. Prognosis strongly …

At the end of the 20th century, more than 930 000 people died of cancer every year in the 15
member countries of the European Union (EU)[1], among a total of 2 500 000 cancer deaths …

Social health insurance (SHI) is enjoying something of a revival in parts of the developing
world. Many countries that have in the past relied largely on tax finance (and out‐of‐pocket …

Background Previous population-based studies revealed major variation in survival for
patients with colorectal cancer (CRC) in Europe by age and between different countries and …

BACKGROUND: The RARECARE project aims at increasing knowledge of rare cancers in
Europe. This manuscript describes the epidemiology (incidence, prevalence, survival) of …